SORT1 and adenocarcinoma: In fact, a highly intriguing finding from our study is that while SORT1 is downregulated in both adenocarcinoma and SCCs, low SORT1 expression is associated with poor outcome in adenocarcinomas, while it marginally appears to be favourable for patients with squamous cancers of the lung.